Skip to content

ACHILLION PHARMACEUTICALS INC

Delisted

CIK 1070336fmd_0HGKCT93Y91X0YYTN769307SGGManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2009 to Sep 30, 2019, 39 periods

Latest annual · FY2016

Millions
Total revenues
15
Operating income
(76)
Net income
(70)
Free cash flow
(63)

Latest quarter · Q2 FY2019

Millions
Total revenues
0
Operating income
(21)
Net income
(20)
Free cash flow
(17)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2013 to FY2016
n/m
Net income, 5 yearsFY2013 to FY2018
n/m

ACHILLION PHARMACEUTICALS INC financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2018FY2017ChangeSource
Operating income-$75.9 million-$89.6 million10-K 2019-03-07 · proof
Net income-$70.3 million-$85.2 million10-K 2019-03-07 · proof
Cash from operating activities-$62 million-$59.5 million10-K 2019-03-07 · proof
Free cash flow-$62.5 million-$60.1 million10-K 2019-03-07 · proof
Total assets$277.9 million$337.6 million-17.7%10-K 2019-03-07 · proof
Total liabilities$11.8 million$13.1 million-9.6%10-K 2019-03-07 · proof
Cash and cash equivalents$49.8 million$43.5 million+14.6%10-K 2019-03-07 · proof
Total debt$131,000$301,000-56.5%10-K 2019-03-07 · proof
What was ACHILLION PHARMACEUTICALS INC's operating income in fiscal 2018?
ACHILLION PHARMACEUTICALS INC reported operating income of -$75.9 million for fiscal 2018 (the year ended Dec 31, 2018), against -$89.6 million the year before. Source: the 10-K filed with the SEC on Mar 7, 2019. SEC
What was ACHILLION PHARMACEUTICALS INC's net income in fiscal 2018?
ACHILLION PHARMACEUTICALS INC reported net income of -$70.3 million for fiscal 2018 (the year ended Dec 31, 2018), against -$85.2 million the year before. Source: the 10-K filed with the SEC on Mar 7, 2019. SEC
What was ACHILLION PHARMACEUTICALS INC's cash from operating activities in fiscal 2018?
ACHILLION PHARMACEUTICALS INC reported cash from operating activities of -$62 million for fiscal 2018 (the year ended Dec 31, 2018), against -$59.5 million the year before. Source: the 10-K filed with the SEC on Mar 7, 2019. SEC
What was ACHILLION PHARMACEUTICALS INC's free cash flow in fiscal 2018?
ACHILLION PHARMACEUTICALS INC reported free cash flow of -$62.5 million for fiscal 2018 (the year ended Dec 31, 2018), against -$60.1 million the year before. Source: the 10-K filed with the SEC on Mar 7, 2019. SEC
What are ACHILLION PHARMACEUTICALS INC's total assets?
As of Dec 31, 2018, ACHILLION PHARMACEUTICALS INC reported total assets of $277.9 million, against $337.6 million a year earlier (-17.7%). Source: the 10-K filed with the SEC on Mar 7, 2019. SEC
What are ACHILLION PHARMACEUTICALS INC's total liabilities?
As of Dec 31, 2018, ACHILLION PHARMACEUTICALS INC reported total liabilities of $11.8 million, against $13.1 million a year earlier (-9.6%). Source: the 10-K filed with the SEC on Mar 7, 2019. SEC
What are ACHILLION PHARMACEUTICALS INC's cash and cash equivalents?
As of Dec 31, 2018, ACHILLION PHARMACEUTICALS INC reported cash and cash equivalents of $49.8 million, against $43.5 million a year earlier (+14.6%). Source: the 10-K filed with the SEC on Mar 7, 2019. SEC
What is ACHILLION PHARMACEUTICALS INC's total debt?
As of Dec 31, 2018, ACHILLION PHARMACEUTICALS INC reported total debt of $131,000, against $301,000 a year earlier (-56.5%). Source: the 10-K filed with the SEC on Mar 7, 2019. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1070336&period_type=annual&limit=5"

Information only, not investment advice.